{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:41:52Z","timestamp":1793752912234,"version":"4.6.1"},"reference-count":69,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.3892\/ijmm.2014.1795","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T09:40:33Z","timestamp":1401874833000},"page":"513-532","source":"Crossref","is-referenced-by-count":26,"title":["Valproic acid, an anti-epileptic drug and a histone deacetylase inhibitor, in combination with proteasome inhibitors exerts antiproliferative, pro-apoptotic and chemosensitizing effects in human colorectal cancer cells: Underlying molecular mechanisms"],"prefix":"10.3892","volume":"34","author":[{"given":"MOHAMED-SALAH I.","family":"ABAZA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ABDUL-MAJEED","family":"BAHMAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RAJA\u2019A J.","family":"AL-ATTIYAH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,6,4]]},"reference":[{"key":"key20180107231049_b1-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1535-7163.MCT-08-0534","article-title":"Vorinostat and bortezomib exert synergistic antiproliferative and proapoptotic effects in colon cancer cell models","volume":"8","author":"Pitts","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"key20180107231049_b2-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid derivatives: A novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J"},{"key":"key20180107231049_b3-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-8722-3-5","article-title":"Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents","volume":"3","author":"Tan","year":"2010","journal-title":"J Hematol Oncol"},{"key":"key20180107231049_b4-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/sj.bjc.6604557","article-title":"Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?","volume":"99","author":"Nolan","year":"2008","journal-title":"Br J Cancer"},{"key":"key20180107231049_b5-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2141.2011.08591.x","article-title":"Bortezomib interacts synergistically with belinostat in human acute myeloid leukaemia and acute lymphoblastic leukaemia cells in association with perturbations in NF-\u03baB and Bim","volume":"153","author":"Dai","year":"2011","journal-title":"Br J Haematol"},{"key":"key20180107231049_b6-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrc1361","article-title":"The proteasome: a suitable antineoplastic target","volume":"4","author":"Adams","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"key20180107231049_b7-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1158\/1078-0432.CCR-07-2218","article-title":"Proteasome inhibitors in cancer therapy: lessons from the first decade","volume":"14","author":"Orlowski","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107231049_b8-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.bbrc.2006.07.185","article-title":"Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cells","volume":"4","author":"Bai","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107231049_b9-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1158\/1078-0432.CCR-03-0561","article-title":"Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors","volume":"11","author":"Pei","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107231049_b10-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s10495-007-0063-y","article-title":"SAHA induces apoptosis in hepatoma cells and synergistically interact with proteasome inhibitor Bortezomib","volume":"12","author":"Emanuele","year":"2007","journal-title":"Apoptosis"},{"key":"key20180107231049_b11-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000156706","article-title":"c-myc anti-sense oligonucleotides sensitize human colorectal cancer cells to chemotherapeutic drugs","volume":"29","author":"Abaza","year":"2008","journal-title":"Tumour Biol"},{"key":"key20180107231049_b12-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3892\/etm_00000106","article-title":"Augmentation of the anticancer effects of proteasome inhibitors by combination with sodium butyrate in human colorectal cancer cells","volume":"1","author":"Abaza","year":"2010","journal-title":"Exp Ther Med"},{"key":"key20180107231049_b13-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"key20180107231049_b14-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1074\/jbc.M106699200","article-title":"Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas\/Fas ligand expression in human acute promyelocytic leukemia cells","volume":"277","author":"Kwon","year":"2002","journal-title":"J Biol Chem"},{"key":"key20180107231049_b15-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/mc.21835","article-title":"Bortezomib-induced sensitization of malignant human glioma cells to vorinostat-induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, noxa upregulation, Mcl-1 cleavage, and DNA damage","volume":"52","author":"Premkumar","year":"2013","journal-title":"Mol Carcinog"},{"key":"key20180107231049_b16-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"17225","DOI":"10.1074\/jbc.C900590199","article-title":"Bcl-2 inhibits a Fas-induced conformational change in the Bax N terminus and Bax mitochondrial translocation","volume":"275","author":"Murphy","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180107231049_b17-ijmm-34-02-0513","first-page":"347","article-title":"Different effects of valproic acid on proliferation and migration of malignant glioma cells in vitro","volume":"21","author":"Knupfer","year":"2001","journal-title":"Anticancer Res"},{"key":"key20180107231049_b18-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4161\/epi.23538","article-title":"Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1\/ETO-positive leukemia cells","volume":"8","author":"Barbetti","year":"2013","journal-title":"Epigenetics"},{"key":"key20180107231049_b19-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1081\/CLT-120014645","article-title":"Valproic acid toxicity: overview and management","volume":"40","author":"Sztanjnkrycer","year":"2002","journal-title":"J Toxicol Clin Toxicol"},{"key":"key20180107231049_b20-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"479364","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","volume":"2010","author":"Chateauvieux","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"key20180107231049_b21-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"37","DOI":"10.14712\/fb2007053020037","article-title":"Valproic acid, a molecular lead to multiple regulatory pathways","volume":"53","author":"Kostrouchov\u00e1","year":"2007","journal-title":"Folia Biol (Praha)"},{"key":"key20180107231049_b22-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1158\/1078-0432.CCR-12-1511","article-title":"Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K\/AKT, and NF-\u03baB","volume":"19","author":"Bastian","year":"2013","journal-title":"Clin Cancer Res"},{"key":"key20180107231049_b23-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"e64600","DOI":"10.1371\/journal.pone.0064600","article-title":"HDAC up-regulation in early colon field carcinogenesis is involved in cell tumorigenicity through regulation of chromatin structure","volume":"8","author":"Stypula-Cyrus","year":"2013","journal-title":"PLoS One"},{"key":"key20180107231049_b24-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"180363","DOI":"10.1155\/2012\/180363","article-title":"Mechanism of growth inhibition of prostate cancer xenografts by valproic acid","volume":"2012","author":"Sidana","year":"2012","journal-title":"J Biomed Biotech"},{"key":"key20180107231049_b25-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0022-5223(03)01321-7","article-title":"Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer","volume":"127","author":"Denlinger","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key20180107231049_b26-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1096\/fasebj.14.1.65","article-title":"Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells","volume":"14","author":"Drexler","year":"2000","journal-title":"FASEB J"},{"key":"key20180107231049_b27-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1073\/pnas.070047997","article-title":"Bax degradation by the ubiquitin\/proteasome-dependent pathway: involvement in tumor survival and progression","volume":"97","author":"Li","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"key20180107231049_b28-ijmm-34-02-0513","first-page":"2615","article-title":"Proteasome inhibitors: a novel class of potent and effective antitumor agents","volume":"59","author":"Adams","year":"1999","journal-title":"Cancer Res"},{"key":"key20180107231049_b29-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1182\/blood.V92.11.4220","article-title":"Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes","volume":"92","author":"Chandra","year":"1998","journal-title":"Blood"},{"key":"key20180107231049_b30-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood-2006-03-013128","article-title":"NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells","volume":"110","author":"Miller","year":"2007","journal-title":"Blood"},{"key":"key20180107231049_b31-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1600-0609.2007.00995.x","article-title":"Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma","volume":"80","author":"Heider","year":"2008","journal-title":"Eur J Haematol"},{"key":"key20180107231049_b32-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1124\/mol.105.017855","article-title":"Valproic acid increases conservative homologous recombination frequency and reactive oxygen species formation: a potential mechanism for valproic acid-induced neural tube defects","volume":"69","author":"Defoort","year":"2006","journal-title":"Mol Pharmacol"},{"key":"key20180107231049_b33-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1158\/0008-5472.CAN-04-2440","article-title":"Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1\/2 inactivation and the generation of ceramide and reactive oxygen species","volume":"65","author":"Rahmani","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107231049_b34-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ccr.2006.12.013","article-title":"p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis","volume":"11","author":"Dolado","year":"2007","journal-title":"Cancer Cell"},{"key":"key20180107231049_b35-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1158\/1535-7163.MCT-10-1108","article-title":"Carfilzomib interact synergistically with histone deacetylase inhibitors in mantle cell lymphoma cells in vitro and in vivo","volume":"10","author":"Dasmahapatra","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"key20180107231049_b36-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1073\/pnas.0408732102","article-title":"Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors","volume":"102","author":"Ungerstedt","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107231049_b37-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.cdd.4402233","article-title":"Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells","volume":"15","author":"Chen","year":"2008","journal-title":"Cell Death Differ"},{"key":"key20180107231049_b38-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/sj.onc.1210677","article-title":"Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis","volume":"27","author":"Kr\u00e4mer","year":"2008","journal-title":"Oncogene"},{"key":"key20180107231049_b39-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.3109\/10428194.2012.698273","article-title":"Synergistic\/additive interaction of valproic acid with bortezomib on proliferation and apoptosis of acute myeloid leukemia cells","volume":"53","author":"Nile","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"key20180107231049_b40-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-4827(02)00027-7","article-title":"Necrosis: a specific form of programmed cell death?","volume":"283","author":"Proskuryakov","year":"2003","journal-title":"Exp Cell Res"},{"key":"key20180107231049_b41-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/sj.onc.1201324","article-title":"The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death","volume":"15","author":"Hirsch","year":"1997","journal-title":"Oncogene"},{"key":"key20180107231049_b42-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2121-6-37","article-title":"HDACs and the senescent phenotype of WI-38 cells","volume":"6","author":"Place","year":"2005","journal-title":"BMC Cell Biol"},{"key":"key20180107231049_b43-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"18030","DOI":"10.1073\/pnas.0408345102","article-title":"Apoptotic and autophagic cell death induced by histone deacetylase inhibitors","volume":"101","author":"Shao","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107231049_b44-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1158\/1535-7163.MCT-05-0184","article-title":"Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastoma by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC","volume":"4","author":"Li","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"key20180107231049_b45-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"Green","year":"1998","journal-title":"Science (Washington DC)"},{"key":"key20180107231049_b46-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.cdd.4400365","article-title":"Bcl-2 family proteins as ion-channels","volume":"5","author":"Schendel","year":"1998","journal-title":"Cell Death Differ"},{"key":"key20180107231049_b47-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0006-2952(02)01154-1","article-title":"Nuclear factor-kappa B and cancer: its role in prevention and therapy","volume":"64","author":"Bharti","year":"2002","journal-title":"Biochem Pharmacol"},{"issue":"Suppl 1","key":"key20180107231049_b48-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0305-7372(03)00083-5","article-title":"Therapeutic anti-cancer targets upstream of the proteasome","volume":"29","author":"Nalepa","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"key20180107231049_b49-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.bcp.2005.04.030","article-title":"HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: Down-regulation of proteasome subunit expression stabilizes I kappa B alpha","volume":"70","author":"Place","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"key20180107231049_b50-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0065-230X(08)60765-4","article-title":"Signal transduction through MAP kinase cascades","volume":"74","author":"Lewis","year":"1998","journal-title":"Adv Cancer Res"},{"key":"key20180107231049_b51-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/sj.leu.2405079","article-title":"Inhibition of MEK\/ERK signaling synergistically potentiates histone deacetylase inhibitor-induced growth arrest, apoptosis and acetylation of histone H3 on p21waf1 promoter in acute myelogenous leukemia cell","volume":"22","author":"Nishioka","year":"2008","journal-title":"Leukemia"},{"key":"key20180107231049_b52-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/leu.2009.41","article-title":"The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia\/lymphoma cells apoptosis","volume":"23","author":"Zhang","year":"2009","journal-title":"Leukemia"},{"key":"key20180107231049_b53-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4161\/cc.3.4.813","article-title":"Ability of the activated PI3K\/Akt oncoproteins to synergize with MEK1 and induce cell cycle progression and abrogate the cytokine-dependence of hematopoietic cells","volume":"3","author":"Shelton","year":"2004","journal-title":"Cell Cycle"},{"key":"key20180107231049_b54-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2005-11-026344","article-title":"Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells","volume":"110","author":"Kawamata","year":"2007","journal-title":"Blood"},{"key":"key20180107231049_b55-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.yexcr.2004.02.001","article-title":"The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib","volume":"295","author":"Yu","year":"2004","journal-title":"Exp Cell Res"},{"key":"key20180107231049_b56-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"544","DOI":"10.4161\/cbt.2.5.454","article-title":"Induction of apoptosis in BCR\/ABL+ cells by histone deacetylase inhibitors involves reciprocal effects on the RAF\/MEK\/ERK and JNK pathways","volume":"2","author":"Yu","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"key20180107231049_b57-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1756-9966-29-149","article-title":"Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line","volume":"29","author":"Yagi","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"key20180107231049_b58-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jinorgbio.2012.04.007","article-title":"Synergistic interaction between the novel histone deacetylase inhibitor ST2782 and the proteasome inhibitor bortezomib in platinum-sensitive and resistant ovarian carcinoma cells","volume":"113","author":"Gatti","year":"2012","journal-title":"J Inorg Biochem"},{"key":"key20180107231049_b59-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s10637-011-9718-1","article-title":"A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL","volume":"30","author":"Hwang","year":"2012","journal-title":"Invest New Drugs"},{"key":"key20180107231049_b60-ijmm-34-02-0513","first-page":"971","article-title":"Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone B","volume":"2","author":"Fuino","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"key20180107231049_b61-ijmm-34-02-0513","first-page":"2503","article-title":"Enhanced growth inhibition and differentiation of fluorodeoxyuridine-treated human colon carcinoma cells by phenylbutyrate","volume":"4","author":"Huang","year":"1998","journal-title":"Clin Cancer Res"},{"key":"key20180107231049_b62-ijmm-34-02-0513","first-page":"7291","article-title":"Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA","volume":"63","author":"Kim","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107231049_b63-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1158\/0008-5472.CAN-03-2631","article-title":"The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells","volume":"64","author":"Maggio","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107231049_b64-ijmm-34-02-0513","first-page":"681","article-title":"Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents","volume":"6","author":"Witzig","year":"2000","journal-title":"Clin Cancer Res"},{"key":"key20180107231049_b65-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"856985","DOI":"10.1155\/2011\/856985","article-title":"Manipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies","volume":"2011","author":"Linares","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"key20180107231049_b66-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/bjc.2011.156","article-title":"A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer","volume":"104","author":"Munster","year":"2011","journal-title":"Br J Cancer"},{"key":"key20180107231049_b67-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.bjc.6603851","article-title":"Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial","volume":"97","author":"Atmaca","year":"2007","journal-title":"Br J Cancer"},{"key":"key20180107231049_b68-ijmm-34-02-0513","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","article-title":"Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors","volume":"34","author":"Duenas-Gonzalez","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"key20180107231049_b69-ijmm-34-02-0513","first-page":"8","article-title":"The role of bioethics in international prescription drug market: economics and global justice","volume":"2","author":"Newland","year":"2006","journal-title":"Penn Bioeth J"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijmm.2014.1795\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T06:46:40Z","timestamp":1746254800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2014.1795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,4]]},"references-count":69,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,6,4]]},"published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.3892\/ijmm.2014.1795"],"URL":"https:\/\/doi.org\/10.3892\/ijmm.2014.1795","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,4]]}}}